EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudie

The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large‐scale global cohort study

Khalaf Kridin iD, Noor Mruwat, Diamant Thaci, Ralf J Ludwig

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.18830 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Khalaf Kridin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lűbeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Psoriasis, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisCardiovascular DiseasesHumansInterleukin-23Cohort StudiesInterleukin-17Interleukin InhibitorsSeverity of Illness Index

Substanzen

Interleukin-23Interleukin-17Interleukin Inhibitors

Autor:innen und Institutionen

  • Lűbeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Unit of Dermatology and Skin Research Laboratory, Barch Padeh Medical Center, Poriya, Israel.
  • Comprehensive Center for Inflammation Medicine, University-Hospital Schleswig-Holstein, Lübeck, Germany.
  • Department of Dermatology, University of Lübeck, Lübeck, Germany.

ORCID-Profile: Khalaf Kridin

Zitieren

APA

Kridin, K., Mruwat, N., Thaci, D., & Ludwig, R. J. (2023). The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large‐scale global cohort study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18830

Vancouver

Kridin K, Mruwat N, Thaci D, Ludwig RJ. The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large‐scale global cohort study. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18830

BibTeX
@article{Kridin2023,
  author = {Kridin, Khalaf and Mruwat, Noor and Thaci, Diamant and Ludwig, Ralf J},
  title = {The cardiometabolic safety of interleukin 23 versus interleukin 17 inhibitors in psoriasis: A large‐scale global cohort study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.18830}
}
Kostenlos starten →